Sign up to our newsletter Subscribe
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies

Patient Reported Outcome Measures (PROMs) are used to evaluate health interventions, providing a measure of an individual’s health status. The EQ-5D is a PROM recommended by NICE for measuring health benefits. It considers 5 dimensions of health and can be used across various diseases.